These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 39003251)
21. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin. Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337 [TBL] [Abstract][Full Text] [Related]
22. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia. Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286 [TBL] [Abstract][Full Text] [Related]
23. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. Pabla N; Ma Z; McIlhatton MA; Fishel R; Dong Z J Biol Chem; 2011 Mar; 286(12):10411-8. PubMed ID: 21285353 [TBL] [Abstract][Full Text] [Related]
24. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis. Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102 [TBL] [Abstract][Full Text] [Related]
25. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. Karakas D; Ozpolat B J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852 [TBL] [Abstract][Full Text] [Related]
26. ZTF-8 interacts with the 9-1-1 complex and is required for DNA damage response and double-strand break repair in the C. elegans germline. Kim HM; Colaiácovo MP PLoS Genet; 2014 Oct; 10(10):e1004723. PubMed ID: 25329393 [TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival. Xie J; Mikolajek H; Pigott CR; Hooper KJ; Mellows T; Moore CE; Mohammed H; Werner JM; Thomas GJ; Proud CG Mol Cell Biol; 2015 May; 35(10):1805-24. PubMed ID: 25776553 [TBL] [Abstract][Full Text] [Related]
28. Elongation factor eEF2 kinase and autophagy jointly promote survival of cancer cells. Lenchine RV; Rao SR; Wang X; Fang DM; Proud CG Biochem J; 2021 Apr; 478(8):1547-1569. PubMed ID: 33779695 [TBL] [Abstract][Full Text] [Related]
29. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533 [TBL] [Abstract][Full Text] [Related]
30. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome. Wang X; Yang Q; Zhou X; Keene CD; Ryazanov AG; Ma T Alzheimers Dement; 2024 Aug; 20(8):5357-5374. PubMed ID: 38934363 [TBL] [Abstract][Full Text] [Related]
31. Contribution of ATM and ATR kinase pathways to p53-mediated response in etoposide and methyl methanesulfonate induced DNA damage. Sun B; Ross SM; Rowley S; Adeleye Y; Clewell RA Environ Mol Mutagen; 2017 Mar; 58(2):72-83. PubMed ID: 28195382 [TBL] [Abstract][Full Text] [Related]
32. Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K. Liu JC; Voisin V; Wang S; Wang DY; Jones RA; Datti A; Uehling D; Al-awar R; Egan SE; Bader GD; Tsao M; Mak TW; Zacksenhaus E EMBO Mol Med; 2014 Dec; 6(12):1542-60. PubMed ID: 25330770 [TBL] [Abstract][Full Text] [Related]
33. Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells. Xie CM; Liu XY; Sham KW; Lai JM; Cheng CH Autophagy; 2014 Sep; 10(9):1495-508. PubMed ID: 24955726 [TBL] [Abstract][Full Text] [Related]
34. Impact of silencing eEF2K expression on the malignant properties of chordoma. Aydemir E; Tüysüz EC; Bayrak ÖF; Tecimel D; Hızlı-Deniz AA; Şahin F Mol Biol Rep; 2023 Apr; 50(4):3011-3022. PubMed ID: 36652154 [TBL] [Abstract][Full Text] [Related]
36. Intrauterine growth restriction inhibits expression of eukaryotic elongation factor 2 kinase, a regulator of protein translation. McKnight RA; Yost CC; Zinkhan EK; Fu Q; Callaway CW; Fung CM Physiol Genomics; 2016 Aug; 48(8):616-25. PubMed ID: 27317589 [TBL] [Abstract][Full Text] [Related]
37. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. Wansleben S; Davis E; Peres J; Prince S Cell Death Dis; 2013 Oct; 4(10):e846. PubMed ID: 24113180 [TBL] [Abstract][Full Text] [Related]
38. cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. Smith EM; Proud CG EMBO J; 2008 Apr; 27(7):1005-16. PubMed ID: 18337751 [TBL] [Abstract][Full Text] [Related]
39. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation. Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884 [TBL] [Abstract][Full Text] [Related]
40. eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA. Wu Y; Xie J; Jin X; Lenchine RV; Wang X; Fang DM; Nassar ZD; Butler LM; Li J; Proud CG Biochem J; 2020 Nov; 477(22):4367-4381. PubMed ID: 33094805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]